由于疫苗接种和筛查率较低,加拿大的子宫颈癌死亡率下降速度不够快,未能达到2040年的消除目标。 Cervical cancer deaths in Canada are not declining fast enough to meet 2040 elimination goals, due to lower vaccination and screening rates.

根据2025年加拿大癌症统计报告,加拿大宫颈癌死亡率自2005年以来一直持平,到2040年消除这一疾病的进展停滞不前。 Cervical cancer mortality rates in Canada have plateaued since 2005, stalling progress toward elimination by 2040, according to a 2025 Canadian Cancer Statistics report. 尽管以前因HPV疫苗接种和筛查而有所下降,但疫苗接种率降低、筛查参与率降低以及后续护理方面存在差距,这些都阻碍了进一步的进展。 Despite prior declines driven by HPV vaccination and screening, lower vaccination rates, reduced screening participation, and gaps in follow-up care are hindering further gains. 该报告预测2025年有430例可预防的宫颈癌死亡,并警告加拿大没有走上实现卫生组织目标的正轨。 The report projects 430 preventable cervical cancer deaths in 2025 and warns Canada is not on track to meet WHO targets. 专家们强调,经过证明的工具,如HPV测试和扩大获得疫苗的机会,可以扭转这一趋势,但迫切需要更广泛的实施、公平获得保健服务以及更有力的公共卫生努力。 Experts stress that proven tools like the HPV test and expanded vaccine access could reverse the trend, but broader implementation, equity in healthcare access, and stronger public health efforts are urgently needed.